Diclofenamide
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
4,5-dichlorobenzene-1,3-disulfonamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601233 |
Legal status | ? |
Pharmacokinetic data | |
Protein binding | 55% |
Identifiers | |
CAS number | 120-97-8 |
ATC code | S01EC02 |
PubChem | CID 3038 |
DrugBank | DB01144 |
ChemSpider | 2930 |
UNII | VVJ6673MHY |
KEGG | D00518 |
ChEBI | CHEBI:101085 |
ChEMBL | CHEMBL17 |
Chemical data | |
Formula | C6H6Cl2N2O4S2 |
Mol. mass | 305.16 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor of the meta-disulfamoylbenzene class.
Uses
Diclofenamide is used to treat glaucoma[1][2] and therapy-resistant epilepsy.[3]
References
- ↑ International Drug Names: Diclofenamide
- ↑ Kanski, J. J. (1968). "Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors". The British journal of ophthalmology 52 (8): 642–643. doi:10.1136/bjo.52.8.642. PMC 506660. PMID 5724852.
- ↑ Rucquoy, M.; Sorel, L. (1978). "Diclofenamide in the treatment of therapy-resistant epilepsy". Acta neurologica Belgica 78 (3): 174–182. PMID 352085.
- Tawil R, McDermott M, Brown R, Shapiro B, Ptacek L, McManis P, Dalakas M, Spector S, Mendell J, Hahn A, Griggs R (2000). "Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis.". Ann Neurol 47 (1): 46–53. doi:10.1002/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H. PMID 10632100.
- Okada S, Izumi W, Murai M, Komatsu H, Ishimitsu S (1991). "[Diclofenamide Reference Standard (Control 891) of National Institute of Hygienic Sciences]". Eisei Shikenjo Hokoku 109 (109): 148–50. PMID 1364383.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.